Even though our findings show a trend towards longer overall survival of pancreatic cancer patients without CD98hc expression, the hypothesis of CD98hc expression being a prognostic factor in this diesase is limited by unavailability of treatment-related data after surgery (e.g. chemotherapy, which might have had a significant influence on overall survival. This evidence concerns the gene SLC3A2 and pancreatic neoplasm.